Ryan Constantine
9Patents
4h-index
31Co-inventors
49Inventor score
Filing activity: May 21, 2004 → Sep 13, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7326711B2 | Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents | Human Necessities | 23 | Expired |
| US7939539B2 | Quinazolinone compounds as anticancer agents | Chemistry; Metallurgy | 23 | Active |
| US7345046B2 | Heteroaryl-fused pyrimidinyl compounds as anticancer agents | Emerging Cross-Sectional Technologies | 19 | Expired |
| US7504405B2 | Mitotic kinesin inhibitors | Chemistry; Metallurgy | 4 | Expired |
| US7576221B2 | Substituted imidazole derivatives | Chemistry; Metallurgy | 3 | Expired |
| US7626040B2 | Substituted imidazole compounds as KSP inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8318791B2 | Substituted imidazole derivatives | Chemistry; Metallurgy | 1 | Active |
| US8735599B2 | Substituted imidazole derivates | Chemistry; Metallurgy | 0 | Active |
| US7452996B2 | Substituted quinoline derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.